Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Pharmacological Inhibition Of The SIRT1 Deacetylase With The Small Molecule Inhibitor Tenovin-6 Enhances Ablation Of FLT3-ITD+ LSC In Combination With TKI Treatment

Ling Li, PhD, Tereza Osdal, MSc, YinWei Ho, MA, Tinisha McDonald, Sookhee Chun, Su Chu, MD, Allen Lin, Cedric Dos Santos, Ph.D, Mihaela Lucia Popa, VMD, Bjorn T Gjertsen, MD PhD, Wenyong Chen, PhD, Sonia Lain, Emmet McCormack, PhD, Ravi Bhatia, MD

Blood (2013) 122 (21): 2685.

https://doi.org/10.1182/blood.V122.21.2685.2685

Published: 2013

Journal Articles

Selective Anti Leukemic Activity Of Low Dose Decitabine In Combination With Ruxolitinib Against Stem/Progenitor Cells From Elderly AML Patients

Cedric Dos Santos, Ph.D, Puneet Agarwal, McDonald Tinisha, Allen Lin, Stephen J. Forman, MD, Ya-Huei Kuo, PhD, Ravi Bhatia, MD

Blood (2013) 122 (21): 2690.

https://doi.org/10.1182/blood.V122.21.2690.2690

Published: 2013

Journal Articles

FLT3-ITD+ AML Stem/Progenitor Cells Demonstrate Increased SIRT1 Expression and Enhanced Sensitivity to SIRT1 Inhibition

Ling Li, PhD, Tinisha McDonald, Liang Li, PhD, Sookhee Chun, Cedric Dos Santos, Ph.D, YinWei Ho, Ravi Bhatia, MD

Blood (2012) 120 (21): 1368.

https://doi.org/10.1182/blood.V120.21.1368.1368

Published: 2012

Journal Articles

Dasatinib Enhances Targeting of Human AML Leukemia Stem Cells by Chemotherapeutic Agents Via Activation of p53

Cedric Dos Santos, Ph.D, Tinisha McDonald, YinWei Ho, Liu Hongjun, Allen Lin, Stephen J Forman, MD, Kuo Ya-Huei, Ph.D, Ravi Bhatia, MD

Blood (2012) 120 (21): 3590.

https://doi.org/10.1182/blood.V120.21.3590.3590

Published: 2012

Journal Articles

CD123-Specific Chimeric Antigen Receptor Redirected T Cells Exhibit Potent Cytolytic Activity and Multiple Effector Functions Against Acute Myeloid Leukemia without Altering Normal Hematopoietic Colony Formation in Vitro

Armen Mardiros, MS, Cedric Dos Santos, Ph.D, Tinisha McDonald, BS, Christine Brown, PhD, Xiuli Wang, MD, PhD, Wen-Chung Chang, MS, Julie R Ostberg, Ph.D, Ravi Bhatia, MD, Michael C. Jensen, MD, Stephen J. Forman, MD

Blood (2012) 120 (21): 950.

https://doi.org/10.1182/blood.V120.21.950.950

Published: 2012

NARROW

Pharmacological Inhibition Of The SIRT1 Deacetylase With The Small Molecule Inhibitor Tenovin-6 Enhances Ablation Of FLT3-ITD+ LSC In Combination With TKI Treatment

Selective Anti Leukemic Activity Of Low Dose Decitabine In Combination With Ruxolitinib Against Stem/Progenitor Cells From Elderly AML Patients

FLT3-ITD+ AML Stem/Progenitor Cells Demonstrate Increased SIRT1 Expression and Enhanced Sensitivity to SIRT1 Inhibition

Dasatinib Enhances Targeting of Human AML Leukemia Stem Cells by Chemotherapeutic Agents Via Activation of p53

CD123-Specific Chimeric Antigen Receptor Redirected T Cells Exhibit Potent Cytolytic Activity and Multiple Effector Functions Against Acute Myeloid Leukemia without Altering Normal Hematopoietic Colony Formation in Vitro

Email alerts

ASH Publications

American Society of Hematology

Pharmacological Inhibition Of The SIRT1 Deacetylase With The Small Molecule Inhibitor Tenovin-6 Enhances Ablation Of FLT3-ITD+ LSC In Combination With TKI Treatment

Selective Anti Leukemic Activity Of Low Dose Decitabine In Combination With Ruxolitinib Against Stem/Progenitor Cells From Elderly AML Patients

FLT3-ITD+ AML Stem/Progenitor Cells Demonstrate Increased SIRT1 Expression and Enhanced Sensitivity to SIRT1 Inhibition

Dasatinib Enhances Targeting of Human AML Leukemia Stem Cells by Chemotherapeutic Agents Via Activation of p53

CD123-Specific Chimeric Antigen Receptor Redirected T Cells Exhibit Potent Cytolytic Activity and Multiple Effector Functions Against Acute Myeloid Leukemia without Altering Normal Hematopoietic Colony Formation in Vitro

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only